Published in J Biol Chem on April 27, 2009
Extracellular TG2: emerging functions and regulation. FEBS J (2011) 1.35
Transglutaminase regulation of cell function. Physiol Rev (2014) 1.28
Cellular functions of tissue transglutaminase. Int Rev Cell Mol Biol (2012) 1.27
Transglutaminase 2: a molecular Swiss army knife. Biochim Biophys Acta (2011) 1.25
Unconventional secretion of tissue transglutaminase involves phospholipid-dependent delivery into recycling endosomes. PLoS One (2011) 1.22
RGD-independent cell adhesion via a tissue transglutaminase-fibronectin matrix promotes fibronectin fibril deposition and requires syndecan-4/2 α5β1 integrin co-signaling. J Biol Chem (2010) 1.05
Characterization of heparin-binding site of tissue transglutaminase: its importance in cell surface targeting, matrix deposition, and cell signaling. J Biol Chem (2012) 1.00
Imaging enzymes at work: metabolic mapping by enzyme histochemistry. J Histochem Cytochem (2010) 0.97
Transglutaminase-2: a new endostatin partner in the extracellular matrix of endothelial cells. Biochem J (2010) 0.94
Transglutaminase 2-specific autoantibodies in celiac disease target clustered, N-terminal epitopes not displayed on the surface of cells. J Immunol (2013) 0.91
Transglutaminase 2 regulates early chondrogenesis and glycosaminoglycan synthesis. Mech Dev (2010) 0.90
Transglutaminase-2 interaction with heparin: identification of a heparin binding site that regulates cell adhesion to fibronectin-transglutaminase-2 matrix. J Biol Chem (2012) 0.87
Retracted The solution structure of heparan sulfate differs from that of heparin: implications for function. J Biol Chem (2011) 0.87
The role of TG2 in regulating S100A4-mediated mammary tumour cell migration. PLoS One (2013) 0.86
A crucial sequence for transglutaminase type 2 extracellular trafficking in renal tubular epithelial cells lies in its N-terminal beta-sandwich domain. J Biol Chem (2011) 0.86
Activity-regulating structural changes and autoantibody epitopes in transglutaminase 2 assessed by hydrogen/deuterium exchange. Proc Natl Acad Sci U S A (2014) 0.84
Transglutaminase 2 is secreted from smooth muscle cells by transamidation-dependent microparticle formation. Amino Acids (2011) 0.84
Syndecan-4 knockout leads to reduced extracellular transglutaminase-2 and protects against tubulointerstitial fibrosis. J Am Soc Nephrol (2013) 0.83
P2X7 receptor activation regulates rapid unconventional export of transglutaminase-2. J Cell Sci (2015) 0.80
The solution structure of heparan sulfate differs from that of heparin: implications for function. J Biol Chem (2013) 0.80
Transglutaminase 2 in cancer. Am J Cancer Res (2015) 0.79
Biological functionalities of transglutaminase 2 and the possibility of its compensation by other members of the transglutaminase family. ScientificWorldJournal (2014) 0.78
Vascular smooth muscle cells remodel collagen matrices by long-distance action and anisotropic interaction. Med Biol Eng Comput (2012) 0.77
The Soft- and Hard-Heartedness of Cardiac Fibroblasts: Mechanotransduction Signaling Pathways in Fibrosis of the Heart. J Clin Med (2017) 0.77
Transglutaminase 2 in cartilage homoeostasis: novel links with inflammatory osteoarthritis. Amino Acids (2016) 0.76
Transglutaminase-2 in cell adhesion: all roads lead to paxillin? Cell Adh Migr (2013) 0.76
Cell Receptor-Basement Membrane Interactions in Health and Disease: A Kidney-Centric View. Curr Top Membr (2015) 0.76
PLA2G5 regulates transglutaminase activity of human IL-4-activated M2 macrophages through PGE2 generation. J Leukoc Biol (2016) 0.75
Abnormally High Content of Free Glucosamine Residues Identified in a Preparation of Commercially Available Porcine Intestinal Heparan Sulfate. Anal Chem (2016) 0.75
Interplay between transglutaminases and heparan sulphate in progressive renal scarring. Sci Rep (2016) 0.75
Tissue transglutaminase-2 promotes gastric cancer progression via the ERK1/2 pathway. Oncotarget (2016) 0.75
Dermatan sulfate is a player in the transglutaminase 2 interaction network. PLoS One (2017) 0.75
Glypican 6 Enhances N-Methyl-D-Aspartate Receptor Function in Human-Induced Pluripotent Stem Cell-Derived Neurons. Front Cell Neurosci (2016) 0.75
Cathepsin-L and transglutaminase dependent processing of ps20: A novel mechanism for ps20 regulation via ECM cross-linking. Biochem Biophys Rep (2016) 0.75
Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature (2007) 7.87
Components of cell-matrix adhesions. J Cell Sci (2001) 7.09
Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol (2003) 6.05
Synergistic control of cell adhesion by integrins and syndecans. Nat Rev Mol Cell Biol (2007) 3.21
Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J Cell Biol (2000) 2.86
Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4. J Clin Invest (2001) 2.78
Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members. J Clin Invest (2007) 2.53
Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function. Science (1994) 2.50
Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J Lipid Res (1999) 2.39
Control of morphology, cytoskeleton and migration by syndecan-4. J Cell Sci (1999) 2.17
Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity. Proc Natl Acad Sci U S A (2002) 2.15
Gene disruption of tissue transglutaminase. Mol Cell Biol (2001) 2.15
A novel pathway for secretory proteins? Trends Biochem Sci (1990) 1.91
Syndecan-4 core protein is sufficient for the assembly of focal adhesions and actin stress fibers. J Cell Sci (1999) 1.76
Protein crosslinking in assembly and remodelling of extracellular matrices: the role of transglutaminases. Connect Tissue Res (2000) 1.74
Syndecan-4 deficiency impairs focal adhesion formation only under restricted conditions. J Biol Chem (2000) 1.55
Tissue transglutaminase is expressed, active, and directly involved in rat dermal wound healing and angiogenesis. FASEB J (1999) 1.53
Differential expression of tissue transglutaminase in human cells. An immunohistochemical study. Cell Tissue Res (1989) 1.44
Molecular basis of elastic fiber formation. Critical interactions and a tropoelastin-fibrillin-1 cross-link. J Biol Chem (2004) 1.42
Tissue transglutaminase in normal and abnormal wound healing: review article. Amino Acids (2004) 1.38
Cell surface localization of tissue transglutaminase is dependent on a fibronectin-binding site in its N-terminal beta-sandwich domain. J Biol Chem (1999) 1.35
Affinity of human erythrocyte transglutaminase for a 42-kDa gelatin-binding fragment of human plasma fibronectin. Proc Natl Acad Sci U S A (1993) 1.29
Analysis of tissue transglutaminase function in the migration of Swiss 3T3 fibroblasts: the active-state conformation of the enzyme does not affect cell motility but is important for its secretion. J Biol Chem (2002) 1.28
Integrin expression and function on human osteoblast-like cells. J Bone Miner Res (1997) 1.28
Transglutaminase-mediated cross-linking is involved in the stabilization of extracellular matrix in human liver fibrosis. J Hepatol (2001) 1.27
Surfen, a small molecule antagonist of heparan sulfate. Proc Natl Acad Sci U S A (2008) 1.26
Reduced expression of tissue transglutaminase in a human endothelial cell line leads to changes in cell spreading, cell adhesion and reduced polymerisation of fibronectin. J Cell Sci (1997) 1.26
Fibronectin-tissue transglutaminase matrix rescues RGD-impaired cell adhesion through syndecan-4 and beta1 integrin co-signaling. J Biol Chem (2008) 1.21
Regulated expression of tissue transglutaminase in Swiss 3T3 fibroblasts: effects on the processing of fibronectin, cell attachment, and cell death. Exp Cell Res (1998) 1.20
Mutation of a critical arginine in the GTP-binding site of transglutaminase 2 disinhibits intracellular cross-linking activity. J Biol Chem (2006) 1.20
Protein kinase C regulates the recruitment of syndecan-4 into focal contacts. Mol Biol Cell (1995) 1.18
The cellular response to transglutaminase-cross-linked collagen. Biomaterials (2005) 1.18
A novel RGD-independent cel adhesion pathway mediated by fibronectin-bound tissue transglutaminase rescues cells from anoikis. J Biol Chem (2003) 1.14
Identification of a novel recognition sequence for fibronectin within the NH2-terminal beta-sandwich domain of tissue transglutaminase. J Biol Chem (2005) 1.14
Tissue transglutaminase and the progression of human renal scarring. J Am Soc Nephrol (2003) 1.14
Cell-surface heparan sulfate proteoglycans are essential components of the unconventional export machinery of FGF-2. Proc Natl Acad Sci U S A (2006) 1.13
Measurement of tissue transglutaminase activity in a permeabilized cell system: its regulation by Ca2+ and nucleotides. Biochem J (1996) 1.11
Evidence that phospholipase delta1 is the effector in the Gh (transglutaminase II)-mediated signaling. J Biol Chem (1996) 1.11
Crosslinking and G-protein functions of transglutaminase 2 contribute differentially to fibroblast wound healing responses. J Cell Sci (2004) 1.10
Unconventional protein secretion: membrane translocation of FGF-2 does not require protein unfolding. J Cell Sci (2004) 1.08
Syndecan-4 associates with alpha-actinin. J Biol Chem (2002) 1.07
Transglutaminase-mediated processing of fibronectin by endothelial cell monolayers. Biochemistry (1994) 1.05
Changes in transglutaminase activity in an experimental model of pulmonary fibrosis induced by paraquat. Br J Exp Pathol (1979) 1.04
Induction of beta3-adrenergic receptor functional expression following chronic stimulation with noradrenaline in neonatal rat cardiomyocytes. J Pharmacol Exp Ther (2005) 1.03
Cell surface counter receptors are essential components of the unconventional export machinery of galectin-1. J Cell Biol (2005) 1.02
Tyrosine phosphorylation of syndecan-1 and -4 cytoplasmic domains in adherent B82 fibroblasts. J Biol Chem (1998) 1.02
Inhibition of transglutaminase activity reduces extracellular matrix accumulation induced by high glucose levels in proximal tubular epithelial cells. J Biol Chem (2004) 1.02
Unconventional secretion: an extracellular trap for export of fibroblast growth factor 2. J Cell Sci (2007) 1.01
Transglutaminase transcription and antigen translocation in experimental renal scarring. J Am Soc Nephrol (1999) 1.00
A method for the non-covalent immobilization of heparin to surfaces. Anal Biochem (2004) 1.00
Cell-surface transglutaminase undergoes internalization and lysosomal degradation: an essential role for LRP1. J Cell Sci (2007) 0.98
Influence of substitution pattern and cation binding on conformation and activity in heparin derivatives. Glycobiology (2007) 0.91
Characterization of tissue transglutaminase in human osteoblast-like cells. J Bone Miner Res (2001) 0.90
Cross-linking of cellular proteins by tissue transglutaminase during necrotic cell death: a mechanism for maintaining tissue integrity. Biochem J (2003) 0.90
Novel interactions of TG2 with heparan sulfate proteoglycans: reflection on physiological implications. Amino Acids (2008) 0.87
Biochemical and cellular mechanisms of pulmonary fibrosis. Toxicol Pathol (1991) 0.86
Osteoblast responses to collagen-PVA bioartificial polymers in vitro: the effects of cross-linking method and collagen content. Biomaterials (1998) 0.86
Interaction with heparin protects tissue transglutaminase against inactivation by heating and by proteolysis. Biochimie (2005) 0.85
Human erythrocyte transglutaminase: purification and preliminary characterisation. Biol Chem Hoppe Seyler (1988) 0.85
Role of the cross-linking enzyme tissue transglutaminase in the biological recognition of synthetic biodegradable polymers. J Biomed Mater Res (2001) 0.84
Determination of amino- and carboxyl-terminal sequences of guinea pig liver transglutaminase: evidence for amino-terminal processing. Biochemistry (1989) 0.76
DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2. J Biol Chem (2003) 2.82
A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics. Cancer Res (2004) 2.72
Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection. Immunity (2002) 2.42
Syndecan-4-dependent Rac1 regulation determines directional migration in response to the extracellular matrix. J Cell Biol (2007) 2.33
Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. J Clin Oncol (2010) 2.30
Cardiovascular events increased at normal and high-normal blood pressure in young and middle-aged Japanese male smokers but not in nonsmokers. J Hypertens (2013) 2.01
An expanded and revised early history of the adenomatoid odontogenic tumor. Oral Surg Oral Med Oral Pathol Oral Radiol (2013) 2.00
N-acetylglucosamine-6-O-sulfotransferases 1 and 2 cooperatively control lymphocyte homing through L-selectin ligand biosynthesis in high endothelial venules. Nat Immunol (2005) 1.91
A major class of L-selectin ligands is eliminated in mice deficient in two sulfotransferases expressed in high endothelial venules. Nat Immunol (2005) 1.89
Randomized study to assess the effect of thrombus aspiration on flow area in patients with ST-elevation myocardial infarction: an optical frequency domain imaging study--TROFI trial. Eur Heart J (2013) 1.87
Loss of MCT1, MCT3, and MCT4 expression in the retinal pigment epithelium and neural retina of the 5A11/basigin-null mouse. Invest Ophthalmol Vis Sci (2003) 1.83
Uric acid and left ventricular hypertrophy in Japanese men. Circ J (2009) 1.79
Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first study. Eur Heart J (2014) 1.78
Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database. J Clin Oncol (2011) 1.78
Midkine and pleiotrophin in neural development and cancer. Cancer Lett (2004) 1.75
Long-Term (>10 Years) clinical outcomes of first-in-human biodegradable poly-l-lactic acid coronary stents: Igaki-Tamai stents. Circulation (2012) 1.72
Age and racial/ethnic differences in drinking and drinking-related problems in a community sample of lesbians. J Stud Alcohol (2006) 1.62
Sulfated polysaccharides increase plasma levels of SDF-1 in monkeys and mice: involvement in mobilization of stem/progenitor cells. Blood (2002) 1.60
Smoking and smoking cessation in relation to all-cause mortality and cardiovascular events in 25,464 healthy male Japanese workers. Circ J (2011) 1.56
Cellular glycosaminoglycans and low density lipoprotein receptor are involved in hepatitis C virus adsorption. J Med Virol (2002) 1.55
Blood management after bilateral total knee arthroplasty. Clin Orthop Relat Res (2003) 1.53
Heparan sulfate/heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)/CXCL12 against proteolysis induced by CD26/dipeptidyl peptidase IV. J Biol Chem (2004) 1.51
The significance of measuring body fat percentage determined by bioelectrical impedance analysis for detecting subjects with cardiovascular disease risk factors. Circ J (2012) 1.48
Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus. Virology (2002) 1.48
Nuclear targeting by the growth factor midkine. Mol Cell Biol (2002) 1.44
Multimarker approach to risk stratification for long-term mortality in patients on chronic hemodialysis. Circ J (2015) 1.41
Sclerosing odontogenic carcinoma: a morphologic pattern or pathologic entity? Oral Surg Oral Med Oral Pathol Oral Radiol (2013) 1.40
Complex bifurcation percutaneous coronary intervention with the Absorb bioresorbable vascular scaffold. EuroIntervention (2013) 1.38
Heparan sulfate targets the HIV-1 envelope glycoprotein gp120 coreceptor binding site. J Biol Chem (2005) 1.38
The cell adhesion molecule "CAR" and sialic acid on human erythrocytes influence adenovirus in vivo biodistribution. PLoS Pathog (2009) 1.37
Impact of body mass index on long-term clinical outcomes after second-generation drug eluting stent implantation: Insights from the international global RESOLUTE program. Catheter Cardiovasc Interv (2015) 1.37
Prediction of depressive distress in a community sample of women: the role of sexual orientation. Am J Public Health (2002) 1.32
What is the relation between cultural orientation and socially desirable responding? J Pers Soc Psychol (2006) 1.28
Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months. EuroIntervention (2014) 1.26
A synthetic CD4-heparan sulfate glycoconjugate inhibits CCR5 and CXCR4 HIV-1 attachment and entry. Nat Chem Biol (2009) 1.25
Patterns of Internet use and impact on patients with melanoma. J Am Acad Dermatol (2005) 1.23
Structural and mutational analysis of human Ad37 and canine adenovirus 2 fiber heads in complex with the D1 domain of coxsackie and adenovirus receptor. J Biol Chem (2006) 1.23
Fibronectin-tissue transglutaminase matrix rescues RGD-impaired cell adhesion through syndecan-4 and beta1 integrin co-signaling. J Biol Chem (2008) 1.21
The cellular response to transglutaminase-cross-linked collagen. Biomaterials (2005) 1.18
Retina-specific expression of 5A11/Basigin-2, a member of the immunoglobulin gene superfamily. Invest Ophthalmol Vis Sci (2003) 1.18
Detection of aggressive primary prostate cancer with 11C-choline PET/CT using multimodality fusion techniques. J Nucl Med (2009) 1.16
The HIV-1 envelope glycoprotein gp120 features four heparan sulfate binding domains, including the co-receptor binding site. J Biol Chem (2008) 1.15
Midkine plays a protective role against cardiac ischemia/reperfusion injury through a reduction of apoptotic reaction. Circulation (2006) 1.15
Regulatory mechanisms of periodontal regeneration. Microsc Res Tech (2003) 1.15
The novel CXCL12gamma isoform encodes an unstructured cationic domain which regulates bioactivity and interaction with both glycosaminoglycans and CXCR4. PLoS One (2007) 1.14
A national survey of tobacco cessation programs for youths. Am J Public Health (2006) 1.13
alpha4beta1- and alpha6beta1-integrins are functional receptors for midkine, a heparin-binding growth factor. J Cell Sci (2004) 1.12
Relationships between glycosaminoglycan and receptor binding sites in chemokines-the CXCL12 example. Carbohydr Res (2008) 1.11
Adenovirus protein involved in virus internalization recruits ubiquitin-protein ligases. Biochemistry (2002) 1.11
Inflammatory chemokines direct and restrict leukocyte migration within live tissues as glycan-bound gradients. Curr Biol (2012) 1.11
Single-vessel or multivessel PCI in patients with multivessel disease presenting with non-ST-elevation acute coronary syndromes. EuroIntervention (2013) 1.09
Primordial odontogenic tumour: is it truly novel? Histopathology (2014) 1.09
Combinational antitumor effect of siRNA against midkine and paclitaxel on growth of human prostate cancer xenografts. Cancer (2006) 1.09
Controlled release of small interfering RNA targeting midkine attenuates intimal hyperplasia in vein grafts. J Vasc Surg (2006) 1.08
Integrated continuous production of recombinant therapeutic proteins. Biotechnol Bioeng (2012) 1.07
Characterization of endostatin binding to heparin and heparan sulfate by surface plasmon resonance and molecular modeling: role of divalent cations. J Biol Chem (2003) 1.07
Structural view of glycosaminoglycan-protein interactions. Carbohydr Res (2006) 1.07
Inhibition of midkine alleviates experimental autoimmune encephalomyelitis through the expansion of regulatory T cell population. Proc Natl Acad Sci U S A (2008) 1.07
The development of performance-monitoring function in the posterior medial frontal cortex. Neuroimage (2009) 1.05
Female infertility in mice deficient in midkine and pleiotrophin, which form a distinct family of growth factors. Genes Cells (2006) 1.05
Midkine, a heparin-binding growth factor, is fundamentally involved in the pathogenesis of rheumatoid arthritis. Arthritis Rheum (2004) 1.04
The relationships of sexual identity, hazardous drinking, and drinking expectancies with risky sexual behaviors in a community sample of lesbian and bisexual women. J Am Psychiatr Nurses Assoc (2013) 1.03
The CXCL12gamma chemokine displays unprecedented structural and functional properties that make it a paradigm of chemoattractant proteins. PLoS One (2008) 1.02
Demonstration of the pleiotrophin-binding oligosaccharide sequences isolated from chondroitin sulfate/dermatan sulfate hybrid chains of embryonic pig brains. J Biol Chem (2005) 1.02
Ghana postgraduate obstetrics/gynecology collaborative residency training program: success story and model for Africa. Am J Obstet Gynecol (2003) 1.02
Human immunodeficiency virus and heparan sulfate: from attachment to entry inhibition. Front Immunol (2013) 1.01
Syndecans promote integrin-mediated adhesion of mesenchymal cells in two distinct pathways. Exp Cell Res (2007) 1.01
The fucose-binding lectin from Ralstonia solanacearum. A new type of beta-propeller architecture formed by oligomerization and interacting with fucoside, fucosyllactose, and plant xyloglucan. J Biol Chem (2005) 1.01
Perioperative morbidity in bilateral one-stage total knee replacements. Clin Orthop Relat Res (2004) 1.01
N-acetylglucosamine 6-O-sulfotransferase-1 regulates expression of L-selectin ligands and lymphocyte homing. J Biol Chem (2004) 1.01
Use of an in vitro model of tissue-engineered skin to investigate the mechanism of skin graft contraction. Tissue Eng (2006) 1.01
Normal human keratinocytes bind to the alpha3LG4/5 domain of unprocessed laminin-5 through the receptor syndecan-1. J Biol Chem (2003) 1.01
Homeostatic and tissue reparation defaults in mice carrying selective genetic invalidation of CXCL12/proteoglycan interactions. Circulation (2012) 1.01
Pleiotrophin triggers inflammation and increased peritoneal permeability leading to peritoneal fibrosis. Kidney Int (2011) 1.00
Sodium-calcium exchangers in rat ameloblasts. J Pharmacol Sci (2010) 1.00
A kinetics and modeling study of RANTES(9-68) binding to heparin reveals a mechanism of cooperative oligomerization. Biochemistry (2002) 1.00
Biological characteristics of the junctional epithelium. J Electron Microsc (Tokyo) (2003) 1.00
Effects of flanking genes on the phenotypes of mice deficient in basigin/CD147. Biochem Biophys Res Commun (2004) 1.00
Heparin-binding growth factor, pleiotrophin, mediates neuritogenic activity of embryonic pig brain-derived chondroitin sulfate/dermatan sulfate hybrid chains. J Biol Chem (2005) 1.00
Growth factor midkine is involved in the pathogenesis of diabetic nephropathy. Am J Pathol (2006) 1.00
Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma. Hepatology (2002) 0.99
Synthesis of tailor-made glycoconjugate mimetics of heparan sulfate that bind IFN-gamma in the nanomolar range. Chemistry (2004) 0.98
Preoperative serum midkine concentration is a prognostic marker for esophageal squamous cell carcinoma. Cancer Sci (2003) 0.98
Functional analysis of the chondroitin 6-sulfotransferase gene in relation to lymphocyte subpopulations, brain development, and oversulfated chondroitin sulfates. J Biol Chem (2001) 0.96
Lack of the growth factor midkine enhances survival against cisplatin-induced renal damage. Am J Pathol (2004) 0.96
Enhanced depth imaging optical coherence tomography of choroidal metastasis in 14 eyes. Retina (2014) 0.95
Identification of tubular heparan sulfate as a docking platform for the alternative complement component properdin in proteinuric renal disease. J Biol Chem (2010) 0.95
Heparan sulphate proteoglycans and viral vectors : ally or foe? Curr Gene Ther (2006) 0.95
Adenovirus dodecahedron cell attachment and entry are mediated by heparan sulfate and integrins and vary along the cell cycle. Virology (2007) 0.95
Direct peptide interaction with surface glycosaminoglycans contributes to the cell penetration of maurocalcine. J Biol Chem (2008) 0.95
Factor h and properdin recognize different epitopes on renal tubular epithelial heparan sulfate. J Biol Chem (2012) 0.95
Heparan sulfate proteoglycan mediates the selective attachment and internalization of serotype 3 human adenovirus dodecahedron. Virology (2004) 0.95
Glycosaminoglycan structures required for strong binding to midkine, a heparin-binding growth factor. Glycobiology (2002) 0.94
Comparison of salivary cytokine levels in oral cancer patients and healthy subjects. Bull Tokyo Dent Coll (2007) 0.94
Cutting edge: C1q binds deoxyribose and heparan sulfate through neighboring sites of its recognition domain. J Immunol (2010) 0.94
Midkine in inflammation. ScientificWorldJournal (2011) 0.94
Bioresorbable drug-eluting magnesium-alloy scaffold for treatment of coronary artery disease. Int J Mol Sci (2013) 0.94